Skip to main content

Probiotics and the Ageing Gut

  • Chapter
Book cover Microbiology and Aging
  • 1440 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Saxelin M, Tynkkynen S, Mattila-Sandholm T, De Vos WM. Probiotics and other functional microbes: from markets to mechanisms. Curr Opin Biotechnol 2005;16:204 –211.

    Article  CAS  PubMed  Google Scholar 

  2. Fooks LJ, Fuller R, Gibson GR. Prebiotics, probiotics and human gut microbiology. Int Dairy J 1999;9:53S –61S.

    Article  Google Scholar 

  3. Sanders ME. Considerations for use of probiotic bacteria to modulate human health. J Nutr 2000;130:384 –390.

    Google Scholar 

  4. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989;66:365 –378.

    CAS  PubMed  Google Scholar 

  5. Anon. Regulatory and clinical aspects of dairy probiotics. Food and agricultural organization of the united nations and world health organisation. Expert consultation report. Food and agriculture organization of the united nations and world health organisation working group report (online). 2001.

    Google Scholar 

  6. McFarland LV, Elmer GW Bioterapeutic agents: past, present and future. Microecol Ther 1995;23:46 –73.

    Google Scholar 

  7. Penner R, Fedorak RN, Madsen KL. Probiotics and nutraceuticals: non-medical treatments of gastrointestinal diseases. Curr Opin Pharmacol 2005;5:596 –603.

    Article  CAS  PubMed  Google Scholar 

  8. Gill HS. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2003;17(5):755 –773.

    Article  CAS  PubMed  Google Scholar 

  9. Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 2004;70(1):518 –526.

    Article  CAS  PubMed  Google Scholar 

  10. Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 2002;82:279 –289.

    Article  CAS  PubMed  Google Scholar 

  11. Fioramonti J, Theodorou V, Bueno L. Probiotics: what are they? What are their effects on gut physiology? Best Pract Res Clin Gastroenterol 2003;17(5):711 –724.

    Article  CAS  PubMed  Google Scholar 

  12. Rinne M, Kalliomäki M, Salminen S, Isolauri E. Probiotic intervention in the first months of life: short-term effects on gastrointestinal symptoms and long-term effects on gut microbiota. J Pediatr Gastroenterol Nutr 2006;43(2):200 –205.

    Article  PubMed  Google Scholar 

  13. Chen CC, Walker WA. Probiotics and prebiotics: role in clinical disease states. Adv Paediatr 2005;52:77 –113.

    Article  Google Scholar 

  14. Walker WA, Duffy LC. Diet and bacterial colonization: role of probiotics and prebiotics. J Nutr Biochem 1998;9:668 –675.

    Article  CAS  Google Scholar 

  15. Tuohy KM, Probert HM, Smejkal CW, Gibson GR. Using probiotics and probiotics to improve gut health. Drug Discov Today 2003;15:692 –701.

    Article  Google Scholar 

  16. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 2004;28:405 –440.

    Article  CAS  PubMed  Google Scholar 

  17. Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: A review. J Am Diet Assoc 2001;101:229 –241.

    Article  CAS  PubMed  Google Scholar 

  18. Isolauri E, Salminen S, Ouwehand AC. Probiotics. Best Pract Res Clin Gastroenterol 2004; 18:299 –313.

    Article  PubMed  Google Scholar 

  19. Isolauri E, Kirjavainen PV, Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 2002;50(suppl III):iii54 –iii59.

    Article  PubMed  Google Scholar 

  20. Agostoni C, Axelsson I, Braegger C, Goulet O, Koletzko B, Michaelsen KF, Rigo J, Shamir R, Szajewska H, Turck D, Weaver LT; ESPGHAN Committee on Nutrition. Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on nutrition. J Pediatr Gastroenterol Nutr 2004;38:365 –374.

    Article  PubMed  Google Scholar 

  21. Glass RI, Lew JF, Gangarosa RE, LeBaron CW, Ho MS. Estimates of morbidity and mortality rates for diarrheal diseases in American children. J Pediatr 1991;118:S27 –S33.

    Article  CAS  PubMed  Google Scholar 

  22. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990;336 (8730):1519 –1523.

    Article  CAS  PubMed  Google Scholar 

  23. Gewolb IH, Schwalbe RS, Taciak VL, Harrison TS, Panigrahi P. Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1999;80(3):F167 –F173.

    Article  CAS  PubMed  Google Scholar 

  24. Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999;3(4):197 –202.

    Article  CAS  PubMed  Google Scholar 

  25. Szajewska H, Kotowska M, Mrukowicz JZ, Armańska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001;138 (3):361 –365

    Article  CAS  PubMed  Google Scholar 

  26. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, Kolacek S, Massar K, Micetic-Turk D, Papadopoulou A, de Sousa JS, Sandhu B, Szajewska H, Weizman Z. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000;30(1):54 –60.

    Article  CAS  PubMed  Google Scholar 

  27. Guarino A, Canani RB, Spagnuolo MI, Albano F, Di Benedetto L. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr 1997;25(5):516 –519.

    Article  CAS  PubMed  Google Scholar 

  28. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88(1):90 –97.

    CAS  PubMed  Google Scholar 

  29. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995;20(3):333 –338.

    Article  CAS  PubMed  Google Scholar 

  30. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994;344(8929):1046 –1049.

    Article  CAS  PubMed  Google Scholar 

  31. Shornikova AV, Casas IA, Isolauri E, Mykkänen H, Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr 1997;24 (4):399 –404.

    Article  CAS  PubMed  Google Scholar 

  32. Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30(11):1604 –1610.

    Article  CAS  PubMed  Google Scholar 

  33. Gill HS, Guarner F. Probiotics and human health: a clinical perspective. Postgrad Med J 2004;80(947):516 –526.

    Article  CAS  PubMed  Google Scholar 

  34. Kalliom äki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007;119(4):1019 –1021.

    Article  PubMed  Google Scholar 

  35. Kalliom äki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 2003;3(1):15 –20.

    Article  PubMed  Google Scholar 

  36. Kalliom äki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003;361 (9372):1869 –1871.

    Article  PubMed  Google Scholar 

  37. Kalliom äki MA, Isolauri E. Probiotics and down-regulation of the allergic response. Immunol Allergy Clin North Am 2004;24(4):739 –752.

    Article  PubMed  Google Scholar 

  38. Gueimonde M, Sakata S, Kalliom äki M, Isolauri E, Benno Y, Salminen S. Effect of maternal consumption of lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J Pediatr Gastroenterol Nutr 2006;42(2):166 –170.

    Article  PubMed  Google Scholar 

  39. Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 2000;78:80 –88.

    Article  CAS  PubMed  Google Scholar 

  40. Goossens D, Jonkers D, Stobberingh E, van den Bogaard A, Russel M, Stockbrugger R. Probiotics in gastroenterology: indications and future perspectives. Scand J Gastroenterol 2003;239:15 –23.

    Google Scholar 

  41. Hamilton-Miller JMT. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents 2003;22:360 –366.

    Article  CAS  PubMed  Google Scholar 

  42. Servin AL, Coconnier MH. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol 2003;17:741 –754.

    Article  CAS  PubMed  Google Scholar 

  43. Franceschi F, Cazzato A, Nista EC, Scarpellini E, Roccarina D, Gigante G, Gasbarrini G, Gasbarrini A. Role of probiotics in patients with Helicobacter pylori infection. Helicobacter 2007;12(2):59 –63.

    Article  PubMed  Google Scholar 

  44. S ýkora J, Valeckov á K, Amlerov á J, Siala K, Dedek P, Watkins S, Varvarovsk á J, Stozick ý F, Pazdiora P, Schwarz J. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 2005;39(8):692 –698.

    Article  PubMed  Google Scholar 

  45. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. Am Soc Nutr Sci 2000;130:396S –402S.

    CAS  Google Scholar 

  46. Thapar N, Sanderson IR. Diarrhoea in children: an interface between developing and developed countries. Lancet 2004;363:641 –653.

    Article  PubMed  Google Scholar 

  47. McNaught CE, MacFie J. Probiotics in clinical practice: a critical review of the evidence. Nutr Res 2001;21:343 –353.

    Article  CAS  Google Scholar 

  48. Reid G, Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 2002;4:319 –324.

    Article  PubMed  Google Scholar 

  49. Saavedra JM. Clinical applications of probiotic agents. Am J Clin Nutr 2001;73:1147S –51S.

    CAS  PubMed  Google Scholar 

  50. Foster JC, Glass MD, Polly D, Ward LA. Effect of Lactobacillus and Bifidobacterium on Cryptosporidium parvum oocyst viability. Food Microbiol 2005;20(3):351 –357.

    Article  Google Scholar 

  51. Sartor R. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005;21:44 –50.

    PubMed  Google Scholar 

  52. Holzapfel WH, Schillinger U. Introduction to pre-and probiotics. Food Res Int 2002; 35:109 –116.

    Article  Google Scholar 

  53. Banaszkiewicz A, Szajewska H. Ineffectiveness of Lactobacillus GG as an adjunct to lactu-lose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial. J Pediatr 2005;146(3):364 –369

    Article  PubMed  Google Scholar 

  54. Sartor R. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004;126:1620 –1633.

    Article  PubMed  Google Scholar 

  55. Reid G, Beuerman D, Heinemann C, Bruce AW. Effect of oral probiotic Lactobacillus therapy on the vaginal flora and susceptibility to urogenital infections. FEMS Immunol Med Micro-biol 2001;32:37 –41.

    Article  CAS  Google Scholar 

  56. Velraeda MC, van der Belt B, van der Mei HC, Reid G, Busscher HJ. Interference in initial adhesion of uropathogenic bacteria and yeasts silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol 1998;49:790 –794.

    Google Scholar 

  57. Eschenbach DA, Thwin SS, Patton DL, Hooton TM, Stapleton AE, Agnew K, Winter C, Meier A, Stamm WE. Influence of the normal menstrual cycle on vaginal tissue, discharge and microflora. Clin Infect Dis 2000;30:901 –907.

    Article  CAS  PubMed  Google Scholar 

  58. Hosoda M, Hashimoto H, He F, Morita H, Hosono A. Effect of administration of milk fermented with Lactobacillus acidophilus LA-2 on fecal mutagenicity and microflora in the human intestine. J Dairy Sci 1996;79(5):745 –749.

    Article  CAS  PubMed  Google Scholar 

  59. Ouwehand AC, Batsman A, Salminen S. Probiotics for the skin: a new area of potential application. Lett Appl Microbiol 2003;36:327 –331.

    Article  CAS  PubMed  Google Scholar 

  60. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 2005;174(6):3237 –3246.

    PubMed  Google Scholar 

  61. O'Mahony L, Feeney M, O'Halloran S, Murphy L, Kiely B, Fitzgibbon J, Lee G, O'Sullivan G, Shanahan F, Collins JK. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 2001;15:1219 –1225.

    Article  PubMed  Google Scholar 

  62. Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, Miyanaga N, Kitamura T, Kawabe K, Kotake T, Kuroda M, Naito S, Koga H, Saito Y, Nomata K, Kitagawa M, Aso Y. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int 2002;68(4): 273 –280.

    Article  CAS  PubMed  Google Scholar 

  63. Gueimonde M, Kalliom äki M, Isolauri E, Salminen S. Probiotic intervention in neonates – will permanent colonization ensue? J Pediatr Gastroenterol Nutr 2006;42(5):604 –606.

    Article  PubMed  Google Scholar 

  64. Chapat L, Chemin K, Dubois B, Bourdet-Sicard R, Kaiserlian D. Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. Eur J Immunol 2004;34(9):2520 –2528.

    Article  CAS  PubMed  Google Scholar 

  65. Kalliom äki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357 (9262):1076 –1079.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Percival, S.L. (2009). Probiotics and the Ageing Gut. In: Percival, S.L. (eds) Microbiology and Aging. Humana Press. https://doi.org/10.1007/978-1-59745-327-1_12

Download citation

Publish with us

Policies and ethics